Kids as young as six are being given weight-loss drugs as a way to curb obesity before it gets too late (opens original article in a new tab)

Children as young as six are being given GLP-1 weight-loss drugs off-label to address obesity, despite limited approval for such young ages and concerns about long-term effects.

• Children as young as six are being prescribed GLP-1 weight-loss drugs off-label to prevent obesity-related health issues
• GLP-1 drugs are approved for children 12 and older but are being tested in younger patients with genetic mutations affecting hunger perception
• Doctors express concerns about long-term effects and nutrient intake for children on weight-loss drugs, with some calling for more studies